Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    Does AstraZeneca plc Pass My Triple Yield Test?

    | Roland Head

    Finding affordable stocks is getting difficult in today's buoyant market. Does AstraZeneca plc (LON:AZN) fit the bill?

    Read more »

    Investing Articles

    What Are AstraZeneca plc’s Dividend Prospects Like Beyond 2014?

    | Royston Wild

    Royston Wild looks at the long-term payout potential of AstraZeneca plc (LON: AZN).

    Read more »

    Investing Articles

    The Investment Case For AstraZeneca plc

    | Tony Reading

    AstraZeneca plc (LON:AZN) is a biotech play that pays a dividend.

    Read more »

    Company Comment

    There’s A Patent Cliff But AstraZeneca plc Has A Jetpack

    | Mark Stones

    How scientific research can put AstraZeneca plc (LON: AZN) back on track for growth.

    Read more »

    Investing Articles

    3 FTSE 100 Shares Hitting New Highs: AstraZeneca plc, Associated British Foods plc and Admiral Group plc

    | Alan Oscroft

    AstraZeneca plc (LON: AZN), Associated British Foods plc (LON: ABF) and Admiral Group plc (LON: ADM) all spike upwards.

    Read more »

    Investing Articles

    3 FTSE 100 Shares Hitting New Highs: Aviva plc, Vodafone Group plc and AstraZeneca plc

    | Alan Oscroft

    Aviva plc (LON: AV), Vodafone Group plc (LON: VOD) and AstraZeneca plc (LON: AZN) are flying even higher.

    Read more »

    Investing Videos

    AstraZeneca Plc Confident Over Revenues Until 2017

    | Owain Bennallack

    VIDEO: One Fool puts AstraZeneca plc (LON:AZN) under the spotlight, and compares it with GlaxoSmithKline plc (LON:GSK).

    Read more »

    Investing Articles

    AstraZeneca plc Upbeat On Revenue Recovery

    | Maynard Paton

    AstraZeneca plc (LON: AZN) says a return to sales growth should come earlier than expected.

    Read more »

    Investing Articles

    Why GlaxoSmithKline plc, AstraZeneca plc and Marks and Spencer Group Plc Should Beat The FTSE 100 Today

    | Alan Oscroft

    GlaxoSmithKline plc (LON: GSK), AstraZeneca plc (LON: AZN) and Marks and Spencer Group Plc (LON: MKS) respond well to news.

    Read more »

    Investing Articles

    The Hidden Nasty In AstraZeneca plc’s Latest Results

    | Roland Head

    AstraZeneca plc (LON:AZN) is a fine company, but Roland Head has noticed a disturbing trend in the firm's clinical trials…

    Read more »

    Investing Articles

    Why AstraZeneca plc Should Be A Winner Next Year

    | Alan Oscroft

    AstraZeneca plc (LON:AZN) is heading back to strength in 2014.

    Read more »

    Investing Articles

    How Will AstraZeneca Plc Fare In 2014?

    | Kevin Godbold

    Should I invest in AstraZeneca plc (LON: AZN) for 2014 and beyond?

    Read more »